Literature DB >> 9663564

Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells.

B von Patay1, H Loppnow, J Feindt, B Kurz, R Mentlein.   

Abstract

The thymus as the major site of T-cell development is exposed to circulating hormones as well as to neurotransmitters released from peripheral nerves. We investigated the influence of catecholamines on the synthesis of interleukin-1 (IL-1) and IL-6 by cultured rat thymic epithelial cells. Basal or lipopolysaccharide (LPS)-stimulated production of IL-1 was not affected by catecholamines. Release of IL-6 was stimulated only scarcely by catecholamines or tumor necrosis factor-alpha (TNF-alpha) and moderately by LPS alone. However, co-stimulation with adrenaline, noradrenaline, or the beta-adrenoceptor agonist isoproterenol (isoprenaline) had an additive (TNF-alpha) or synergistic (LPS) effect on IL-6 release. The synergistic effect was dose-dependent on catecholamine or LPS concentrations. It was mediated by beta-adrenoceptors that are linked to elevation of intracellular cAMP levels, since it was promoted by beta-adrenoceptor agonists and could be blocked by beta-adrenoceptor antagonists. Co-incubation of LPS with agents directly raising cAMP-levels like forskolin or dibutyryl cAMP yielded even stronger IL-6 induction. After co-stimulation IL-6 mRNA was first detected after 3-4 h and a constant increase of IL-6 bioactivity in the culture supernatant was measured for up to 48 h. Since IL-6 is an important factor for thymocyte differentiation and proliferation, the findings demonstrate an influence of neuronal or hormonal catecholamines on the thymic microenvironment that is created by thymic epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663564     DOI: 10.1016/s0165-5728(98)00051-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

Review 2.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

Review 3.  Neuroendocrine regulation of inflammation.

Authors:  Caroline J Padro; Virginia M Sanders
Journal:  Semin Immunol       Date:  2014-01-31       Impact factor: 11.130

Review 4.  Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms.

Authors:  Gregory E Miller; Edith Chen; Karen J Parker
Journal:  Psychol Bull       Date:  2011-11       Impact factor: 17.737

5.  Characterization of thymocyte phenotypic alterations induced by long-lasting beta-adrenoceptor blockade in vivo and its effects on thymocyte proliferation and apoptosis.

Authors:  G Leposavić; N Arsenović-Ranin; K Radojević; D Kosec; V Pesić; B Vidić-Danković; B Plećas-Solarović; I Pilipović
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

Review 6.  Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.

Authors:  Harald Loppnow; Michael Buerke; Karl Werdan; Stefan Rose-John
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

7.  Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures.

Authors:  Harald Loppnow; Li Zhang; Michael Buerke; Michael Lautenschläger; Li Chen; Adrian Frister; Axel Schlitt; Tanja Luther; Nan Song; Britt Hofmann; Stefan Rose-John; Rolf-Edgar Silber; Ursula Müller-Werdan; Karl Werdan
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

8.  Altered bone marrow lymphopoiesis and interleukin-6-dependent inhibition of thymocyte differentiation contribute to thymic atrophy during Trypanosoma cruzi infection.

Authors:  Sofía Carbajosa; Susana Gea; Carlos Chillón-Marinas; Cristina Poveda; María Del Carmen Maza; Manuel Fresno; Núria Gironès
Journal:  Oncotarget       Date:  2017-03-14

Review 9.  Role of Interleukin-6 in Vascular Health and Disease.

Authors:  Paulina Villar-Fincheira; Fernanda Sanhueza-Olivares; Ignacio Norambuena-Soto; Nicole Cancino-Arenas; Felipe Hernandez-Vargas; Rodrigo Troncoso; Luigi Gabrielli; Mario Chiong
Journal:  Front Mol Biosci       Date:  2021-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.